Beam Aktie

Beam für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A1JKNP / ISIN: US0737301038

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
08.08.2023 13:44:41

Beam Therapeutics Q2 Loss Widens But Beats Estimates

(RTTNews) - Beam Therapeutics Inc. (BEAM) on Monday reported higher loss for the second quarter that reflected higher R&D expenses. However, revenue improved from last year. The results also beat market expectations.

Quarterly net loss widened to $82.78 million or $1.08 loss per share from $71.95 million or $1.02 loss last year.

On average, 13 analysts polled by Thomson Reuters expected the company to report a loss of $1.42 per share for the quarter. Analysts' estimates typically exclude one-time items.

Comprehensive loss widened to $84.03 million from $73.43 million of the previous year.

Revenue however, increased to $20.11 million from $16.65 million for the same period, last year. The Street estimate for revenue was $18.05 million

In pre-market activity, shares of Beam Therapeutics are trading at $25.18, down 1.41% on Nasdaq.

Nachrichten zu Beam Inc Cash Settlement At USD 83.50 A Shmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Beam Inc Cash Settlement At USD 83.50 A Shmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!